Research ExplorerPublicationsErratum to: Biomodulatory Treatment of Patients with Castrat...

Erratum to: Biomodulatory Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and Low-Dose Treosulfan

Standard

Erratum to: Biomodulatory Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and Low-Dose Treosulfan. / Vogelhuber, M; Feyerabend, S; Stenzl, A; Suedhoff, T; Schulze, M; Huebner, J; Oberneder, R; Wieland, W; Mueller, S; Eichhorn, F; Heinzer, H; Schmidt, K; Baier, M; Ruebel, A; Birkholz, K; Bakhshandeh-Bath, A; Andreesen, R; Herr, W; Reichle, A.

In: CANCER MICROENVIRON, Vol. 8, No. 1, 05.02.2015, p. 43-44.

Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

Harvard

Vogelhuber, M, Feyerabend, S, Stenzl, A, Suedhoff, T, Schulze, M, Huebner, J, Oberneder, R, Wieland, W, Mueller, S, Eichhorn, F, Heinzer, H, Schmidt, K, Baier, M, Ruebel, A, Birkholz, K, Bakhshandeh-Bath, A, Andreesen, R, Herr, W & Reichle, A 2015, 'Erratum to: Biomodulatory Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and Low-Dose Treosulfan', CANCER MICROENVIRON, vol. 8, no. 1, pp. 43-44. https://doi.org/10.1007/s12307-015-0165-y

APA

Vogelhuber, M., Feyerabend, S., Stenzl, A., Suedhoff, T., Schulze, M., Huebner, J., Oberneder, R., Wieland, W., Mueller, S., Eichhorn, F., Heinzer, H., Schmidt, K., Baier, M., Ruebel, A., Birkholz, K., Bakhshandeh-Bath, A., Andreesen, R., Herr, W., & Reichle, A. (2015). Erratum to: Biomodulatory Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and Low-Dose Treosulfan. CANCER MICROENVIRON, 8(1), 43-44. https://doi.org/10.1007/s12307-015-0165-y

Vancouver

Vogelhuber M, Feyerabend S, Stenzl A, Suedhoff T, Schulze M, Huebner J et al. Erratum to: Biomodulatory Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and Low-Dose Treosulfan. CANCER MICROENVIRON. 2015 Feb 5;8(1):43-44. https://doi.org/10.1007/s12307-015-0165-y

Bibtex

@article{12c1d42fd56146f0aa86973d288cf404,
title = "Erratum to: Biomodulatory Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and Low-Dose Treosulfan",
author = "M Vogelhuber and S Feyerabend and A Stenzl and T Suedhoff and M Schulze and J Huebner and R Oberneder and W Wieland and S Mueller and F Eichhorn and H Heinzer and K Schmidt and M Baier and A Ruebel and K Birkholz and A Bakhshandeh-Bath and R Andreesen and W Herr and A Reichle",
note = "Erratum",
year = "2015",
month = feb,
day = "5",
doi = "10.1007/s12307-015-0165-y",
language = "English",
volume = "8",
pages = "43--44",
journal = "CANCER MICROENVIRON",
issn = "1875-2292",
publisher = "Springer Netherlands",
number = "1",

}

RIS

TY - JOUR

T1 - Erratum to: Biomodulatory Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and Low-Dose Treosulfan

AU - Vogelhuber, M

AU - Feyerabend, S

AU - Stenzl, A

AU - Suedhoff, T

AU - Schulze, M

AU - Huebner, J

AU - Oberneder, R

AU - Wieland, W

AU - Mueller, S

AU - Eichhorn, F

AU - Heinzer, H

AU - Schmidt, K

AU - Baier, M

AU - Ruebel, A

AU - Birkholz, K

AU - Bakhshandeh-Bath, A

AU - Andreesen, R

AU - Herr, W

AU - Reichle, A

N1 - Erratum

PY - 2015/2/5

Y1 - 2015/2/5

U2 - 10.1007/s12307-015-0165-y

DO - 10.1007/s12307-015-0165-y

M3 - Other (editorial matter etc.)

C2 - 25651886

VL - 8

SP - 43

EP - 44

JO - CANCER MICROENVIRON

JF - CANCER MICROENVIRON

SN - 1875-2292

IS - 1

ER -